Sofipaca

Total investments

12

Average round size

4M

Portfolio companies

12

Lead investments

1

Exits

2

Areas of investment
Information TechnologyFood and BeverageFitnessHealth DiagnosticsWellnessManufacturingMedicalPharmaceuticalPackaging ServicesBuilding Maintenance

Summary

The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Bloomup, Carru00e9 d'Artistes, Altrad Group We can highlight the next thriving fund investment areas, such as Craft Beer, Art.

The top activity for fund was in 2017. Comparing to the other companies, this Sofipaca performs on 19 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.

The standard case for the fund is to invest in rounds with 3-4 partakers. The meaningful sponsors for the fund in investment in the same round are IDIA Capital Investissement, Paca Investissement, Bpifrance. In the next rounds fund is usually obtained by Societe Generale, CM-CIC Innovation, BNP Paribas Private Equity.

Show more

Investments analytics

Analytics

Total investments
12
Lead investments
1
Exits
2
Investments by industry
  • Manufacturing (3)
  • Pharmaceutical (2)
  • Food and Beverage (2)
  • Information Technology (2)
  • Health Diagnostics (1)
  • Show 23 more
Investments by region
  • France (12)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
29
Avg. valuation at time of investment
25M
Group Appearance index
1.00
Avg. company exit year
14
Avg. multiplicator
1.36

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Provepharm life Solutions 01 Dec 2011 Life Science, Pharmaceutical Early Stage Venture 3M Provence-Alpes-Côte d'Azur, Marseille, France
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.